A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity
Chemistry – A European Journal · 03.11.2026 · 32 (41)
DOI: 10.1002/chem.71531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 13.08.2026. Verfasst von Wudama Cui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Therapy, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medica…. Hauptthemen laut MEDLINE: Cisplatin, Photosensitizing Agents, Mitochondria, Antineoplastic Agents. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Inner Mongolia Natural Science Fund, National Natural Science Foundation of China, Science Research Project of Hebei Education Department.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy remains a major strategy for cancer treatment, with cisplatin widely used as a first‐line agent for diverse malignancies. Although cisplatin efficiently induces tumor cell death through DNA damage, its therapeutic efficacy is often limited by the development of an immunosuppressive tumor microenvironment that restricts effective immune activation. Here, we report a rationally engineered photosensitizer, CMPE, featuring efficient reactive oxygen species (ROS) generation and precise mitochondrial targeting. Upon spatially controlled light activation, CMPE induces mitochondrial oxidative stress and, in combination with cisplatin, triggers potent immunogenic cell death accompanied by robust release of damage‐associated molecular patterns that promote immune cell maturation and activation. In vivo, CMPE in combination with cisplatin enhances CD8 + T‐cell infiltration while reducing immunosuppressive cell populations, thereby converting immunologically “cold” tumors into an immune‐active phenotype and ultimately leading to significant tumor growth inhibition. Moreover, tumor cells pretreated with CMPE, either alone or combined with cisplatin, function as an effective whole‐cell vaccine that elicits durable immune memory and suppresses tumor recurrence. These findings demonstrate that a mitochondria‐targeted photosensitizer can serve as an effective platform for synergistic chemo‐photodynamic immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Therapy, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, P. R. China.
- Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, P. R. China.
- College of Life Sciences, Hebei Agricultural University, Baoding, P. R. China.
- Department of Ultrasound Medicine, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, P. R. China.
ORCID-Profile: Duo Mao
Förderung
- Inner Mongolia Natural Science Fund
- National Natural Science Foundation of China
- Science Research Project of Hebei Education Department
Zitieren
APA
Cui, W., Li, M., Bai, Q., He, N. S. M., Yao, S., An, Y., Li, E., Chen, X., Meng, Y., Wu, X., Mao, D., Wang, J., & Yu, H. (2026). A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity. Chemistry – A European Journal, 32(41). https://doi.org/10.1002/chem.71531
Vancouver
Cui W, Li M, Bai Q, He NSM, Yao S, An Y, et al. A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity. Chemistry – A European Journal. 2026;32(41). doi:10.1002/chem.71531
BibTeX
@article{Cui2026,
author = {Cui, Wudama and Li, Min and Bai, Qingqing and He, Na Shun Meng and Yao, Shun and An, Yanhe and Li, Enyu and Chen, Xuebo and Meng, Yajun and Wu, Xinghua and Mao, Duo and Wang, Juan and Yu, Hai},
title = {A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {41},
doi = {10.1002/chem.71531}
}
EUVIMED